NCT06598943 A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis Status RECRUITING Phase PHASE2
NCT06598631 Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease Status WITHDRAWN Phase PHASE2
NCT06594679 A Study of Niraparib in Combination With Abemaciclib for Late Line Treatment of Ovarian Cancer (NICHOL TRIAL) Status RECRUITING Phase PHASE1/PHASE2
NCT06588478 A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Status RECRUITING Phase PHASE2
NCT06588296 Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight Status COMPLETED Phase PHASE3
NCT06588283 Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06586515 MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors Status RECRUITING Phase PHASE1
NCT06584916 A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN) Status COMPLETED Phase PHASE3
NCT06568042 Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06566170 A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease Status RECRUITING Phase N/A
NCT06561685 A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06553872 Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL Status RECRUITING Phase PHASE2
NCT06538116 A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06522386 GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06517888 Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma Status RECRUITING Phase PHASE1/PHASE2
NCT06515418 Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over Status TERMINATED Phase PHASE2
NCT06475729 A Bioequivalence Study of Citrate Free Mirikizumab (LY3074828) in Healthy Participants Status COMPLETED Phase PHASE1